$CNFN
CFN Enterprises Inc. Stock $cnfn

$cnfn Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000109690623001595 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$1.679M	$152.3K
YoY Change	99.6%	-89.63%
Cost Of Revenue	$1.226M	$47.48K
YoY Change	-6.44%	-97.76%
Gross Profit	$453.0K	$104.8K
YoY Change	-196.62%	-116.16%
Gross Profit Margin	26.99%	68.82%
Selling, General & Admin	$1.598M	$1.703M
YoY Change	211.32%	117.19%
% of Gross Profit	352.66%	1624.86%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$45.33K	$2.831K
YoY Change	-89.24%	-99.3%
% of Gross Profit	10.01%	2.7%
Operating Expenses	$1.598M	$1.703M
YoY Change	211.32%	117.19%
Operating Profit	-$1.145M	-$1.598M
YoY Change	16.55%	11.54%
Interest Expense	$765.9K	$37.45K
YoY Change	564.53%	-64.69%
% of Operating Profit
Other Income/Expense, Net	-$765.8K	$142.6K
YoY Change	447.17%	-521.25%
Pretax Income	-$1.910M	-$1.456M
YoY Change	70.27%	-0.76%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.910M	-$1.456M
YoY Change	70.2%	-0.76%
Net Earnings / Revenue	-113.82%	-955.81%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.02	-$0.04
COMMON SHARES
Basic Shares Outstanding	82.21M shares	40.09M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.741M	$1.048M
YoY Change	1468.34%	589.04%
Cash & Equivalents	$1.741M	$1.048M
Short-Term Investments
Other Short-Term Assets	$94.62K	$20.28K
YoY Change	-20.42%	-83.24%
Inventory	$1.865M	$0.00
Prepaid Expenses	$74.25K
Receivables	$712.9K	$36.10K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$4.413M	$1.105M
YoY Change	1361.47%	188.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$164.8K	$47.91K
YoY Change	252.34%	2.19%
Goodwill	$8.676M
YoY Change
Intangibles
YoY Change
Long-Term Investments	$297.3K
YoY Change	48.64%
Other Assets	$55.68K	$55.68K
YoY Change	19.05%	18.77%
Total Long-Term Assets	$15.99M	$1.477M
YoY Change	172.27%	-77.18%
TOTAL ASSETS
Total Short-Term Assets	$4.413M	$1.105M
Total Long-Term Assets	$15.99M	$1.477M
Total Assets	$15.99M	$1.477M
YoY Change	172.27%	-77.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.487M	$2.318M
YoY Change	-1.94%	-3.64%
Accrued Expenses	$3.318M	$2.437M
YoY Change	56.61%	29.32%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.854M	$3.795M
YoY Change	180.47%	116.6%
Total Short-Term Liabilities	$12.45M	$9.459M
YoY Change	74.0%	37.75%
LONG-TERM LIABILITIES
Long-Term Debt	$4.072M	$746.2K
YoY Change	115.49%	-54.14%
Other Long-Term Liabilities	$1.724M	$223.8K
YoY Change	508.55%	-60.46%
Total Long-Term Liabilities	$4.072M	$746.2K
YoY Change	115.49%	-54.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.45M	$9.459M
Total Long-Term Liabilities	$4.072M	$746.2K
Total Liabilities	$18.24M	$10.43M
YoY Change	95.61%	15.11%
SHAREHOLDERS EQUITY
Retained Earnings	-$63.09M	-$61.12M
YoY Change	19.26%	18.17%
Common Stock	$82.21K	$41.71K
YoY Change	143.07%	23.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.252M	-$8.952M
YoY Change
Total Liabilities & Shareholders Equity	$15.99M	$1.477M
YoY Change	172.27%	-77.18%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$1.910M	-$1.456M
YoY Change	70.2%	-0.76%
Depreciation, Depletion And Amortization	$45.33K	$2.831K
YoY Change	-89.24%	-99.3%
Cash From Operating Activities	-$3.202M	$22.00K
YoY Change	3803.5%	-101.74%
INVESTING ACTIVITIES
Capital Expenditures	$162.2K	$0.00
YoY Change	260.44%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$134.1K	$608.3K
YoY Change
Cash From Investing Activities	-$28.14K	$608.3K
YoY Change	-162.53%	-483.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.923M	399.3K
YoY Change	18841.14%	-72.29%
NET CHANGE
Cash From Operating Activities	-3.202M	22.00K
Cash From Investing Activities	-28.14K	608.3K
Cash From Financing Activities	3.923M	399.3K
Net Change In Cash	692.9K	1.030M
YoY Change	-4348.44%	6838.07%
FREE CASH FLOW
Cash From Operating Activities	-$3.202M	$22.00K
Capital Expenditures	$162.2K	$0.00
Free Cash Flow	-$3.364M	$22.00K
YoY Change	2548.28%	-101.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-52635
	dei	Entity Registrant Name EntityRegistrantName	CFN ENTERPRISES INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1559541
	dei	Entity Address Address Line1 EntityAddressAddressLine1	600 E. 8TH STREET
	dei	Entity Address City Or Town EntityAddressCityOrTown	WHITEFISH
	dei	Entity Address Country EntityAddressCountry	MT
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	59937
	dei	Country Region CountryRegion	833
	dei	City Area Code CityAreaCode	420
	dei	Local Phone Number LocalPhoneNumber	2636
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	82210664	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1048166	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12474	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	20284	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	20128	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36100	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	28245	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	1104550	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	60847	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47907	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	53570	usd
CY2023Q2	fil	Right Of Use Asset RightOfUseAsset	268696	usd
CY2022Q4	fil	Right Of Use Asset RightOfUseAsset	110321	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	55676	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	46766	usd
CY2023Q2	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	0	usd
CY2022Q4	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	599047	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1476829	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	870551	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2318201	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2357614	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2436785	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2343654	usd
CY2023Q2	fil	Payments In Advance Of Securities Date PaymentsInAdvanceOfSecuritiesDate	0	usd
CY2022Q4	fil	Payments In Advance Of Securities Date PaymentsInAdvanceOfSecuritiesDate	217500	usd
CY2023Q2	fil	Due To Related Party DueToRelatedParty	501140	usd
CY2022Q4	fil	Due To Related Party DueToRelatedParty	503259	usd
CY2023Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	16327	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10978	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	3794914	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	3088250	usd
CY2023Q2	fil	Current Portion Of Right Of Use Liability CurrentPortionOfRightOfUseLiability	312033	usd
CY2022Q4	fil	Current Portion Of Right Of Use Liability CurrentPortionOfRightOfUseLiability	262727	usd
CY2023Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	79823	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	79823	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	9459223	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8863805	usd
CY2023Q2	fil	Right Of Use Liability RightOfUseLiability	223822	usd
CY2022Q4	fil	Right Of Use Liability RightOfUseLiability	200758	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	746180	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	978337	usd
CY2023Q2	us-gaap	Liabilities Liabilities	10429225	usd
CY2022Q4	us-gaap	Liabilities Liabilities	10042900	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41710664	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41710664	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37690664	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37690664	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	41710	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	37690	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52128924	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49786056	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61123034	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-58996099	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-8952396	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-9172349	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1476829	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	870551	usd
CY2023Q2	us-gaap	Revenues Revenues	152301	usd
CY2022Q2	us-gaap	Revenues Revenues	1468373	usd
	us-gaap	Revenues Revenues	265259	usd
	us-gaap	Revenues Revenues	2987664	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	47484	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	2117165	usd
	us-gaap	Cost Of Revenue CostOfRevenue	223675	usd
	us-gaap	Cost Of Revenue CostOfRevenue	4400848	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	104817	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	-648792	usd
	us-gaap	Gross Profit GrossProfit	41584	usd
	us-gaap	Gross Profit GrossProfit	-1413184	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1703134	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	784174	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2125148	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1275672	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1703134	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	784174	usd
	us-gaap	Operating Expenses OperatingExpenses	2125148	usd
	us-gaap	Operating Expenses OperatingExpenses	1275672	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1598317	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1432966	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2083564	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2688856	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	37450	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	106071	usd
	us-gaap	Interest Expense InterestExpense	103501	usd
	us-gaap	Interest Expense InterestExpense	152387	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	9253	usd
CY2022Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	87933	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	9253	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	87933	usd
CY2023Q2	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	0	usd
CY2022Q2	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-19494	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	0	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-19494	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	13219	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	13219	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q2	us-gaap	Other Income OtherIncome	157502	usd
CY2022Q2	us-gaap	Other Income OtherIncome	3772	usd
	us-gaap	Other Income OtherIncome	157502	usd
	us-gaap	Other Income OtherIncome	3772	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	81	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	7	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	157	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	9	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	142605	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-33853	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	76630	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-80167	usd
CY2023Q2	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	usd
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	usd
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1455712	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1466819	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2006934	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2769023	usd
CY2023Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	60000	usd
CY2022Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	60000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	120000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	120000	usd
CY2023Q2	fil	Net Loss Available To Common Shareholders NetLossAvailableToCommonShareholders	-1515712	usd
CY2022Q2	fil	Net Loss Available To Common Shareholders NetLossAvailableToCommonShareholders	-1526819	usd
	fil	Net Loss Available To Common Shareholders NetLossAvailableToCommonShareholders	-2126934	usd
	fil	Net Loss Available To Common Shareholders NetLossAvailableToCommonShareholders	-2889023	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	22	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	45	usd
CY2023Q2	fil	Net Loss Available To Cfn Enterprises Common Shareholders NetLossAvailableToCfnEnterprisesCommonShareholders	-1515712	usd
CY2022Q2	fil	Net Loss Available To Cfn Enterprises Common Shareholders NetLossAvailableToCfnEnterprisesCommonShareholders	-1526841	usd
	fil	Net Loss Available To Cfn Enterprises Common Shareholders NetLossAvailableToCfnEnterprisesCommonShareholders	-2126934	usd
	fil	Net Loss Available To Cfn Enterprises Common Shareholders NetLossAvailableToCfnEnterprisesCommonShareholders	-2889068	usd
CY2023Q2	fil	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.04
CY2022Q2	fil	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.04
	fil	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.05
	fil	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.09
CY2023Q2	fil	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	40846664	shares
CY2022Q2	fil	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	33346183	shares
	fil	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	40255331	shares
	fil	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	32512832	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2395743	usd
CY2022Q1	fil	Payment Of Csis Debt By Shareholder PaymentOfCsisDebtByShareholder	415875	usd
CY2022Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	60000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1302205	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-3342072	usd
CY2022Q2	fil	Issuance Of Common Stock For Proceeds IssuanceOfCommonStockForProceeds	800020	usd
CY2022Q2	fil	Purchase Of Property And Equipment With Common Stock PurchaseOfPropertyAndEquipmentWithCommonStock	700000	usd
CY2022Q2	fil	Warrants Issued With Promissory Notes WarrantsIssuedWithPromissoryNotes	302537	usd
CY2022Q2	fil	Payment Of Csis Debt By Shareholder PaymentOfCsisDebtByShareholder	477723	usd
CY2022Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	60000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1466819	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2588614	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9172349	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	600000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	60000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-551222	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9183571	usd
CY2023Q2	fil	Shares Issued As Payment For Accrued Interest Value SharesIssuedAsPaymentForAccruedInterestValue	405000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1450942	usd
CY2023Q2	fil	Warrants Issued In Connection With Note Payable WarrantsIssuedInConnectionWithNotePayable	185788	usd
CY2023Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	60000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1455712	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8952396	usd
	us-gaap	Profit Loss ProfitLoss	-2006934	usd
	us-gaap	Profit Loss ProfitLoss	-2769023	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5663	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	788452	usd
	fil	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	29488	usd
	fil	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	97090	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	16349	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1156100	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	9253	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	87933	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	13219	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-19494	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	34826	usd
	fil	Non Controlling Interest NonControllingInterest	0	usd
	fil	Non Controlling Interest NonControllingInterest	-45	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7855	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-94059	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-96113	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8910	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-9250	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	351937	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	540235	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	5349	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-7366	usd
	fil	Payments Made In Advance Of Securities Date PaymentsMadeInAdvanceOfSecuritiesDate	32500	usd
	fil	Payments Made In Advance Of Securities Date PaymentsMadeInAdvanceOfSecuritiesDate	0	usd
	fil	Increase Decrease In Right Of Use Liability IncreaseDecreaseInRightOfUseLiability	-115493	usd
	fil	Increase Decrease In Right Of Use Liability IncreaseDecreaseInRightOfUseLiability	-120712	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-564277	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1305560	usd
	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	-608300	usd
	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	0	usd
	fil	Purchase Of Property And Equipment Net PurchaseOfPropertyAndEquipmentNet	0	usd
	fil	Purchase Of Property And Equipment Net PurchaseOfPropertyAndEquipmentNet	-172588	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	608300	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-172588	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-2119	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	5443	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1175000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1233000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	531056	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	15206	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	350000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	210000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	991825	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1433237	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1035848	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-44911	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32602	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190029	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1068450	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	145118	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12474	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	170015	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	20128	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	20014	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	32602	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	190029	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1048166	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	125095	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	20284	usd
CY2022Q2	us-gaap	Restricted Cash RestrictedCash	20023	usd
CY2023Q2	fil	Cash And Restricted Cash At End Of Period CashAndRestrictedCashAtEndOfPeriod	1068450	usd
CY2022Q2	fil	Cash And Restricted Cash At End Of Period CashAndRestrictedCashAtEndOfPeriod	145118	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Interest Paid InterestPaid	0	usd
	us-gaap	Interest Paid InterestPaid	0	usd
	fil	Conversion Of Accrued Preferred Stock Interest Into Shares ConversionOfAccruedPreferredStockInterestIntoShares	405000	usd
	fil	Conversion Of Accrued Preferred Stock Interest Into Shares ConversionOfAccruedPreferredStockInterestIntoShares	0	usd
	fil	Right Of Use Asset And Liability RightOfUseAssetAndLiability	187863	usd
	fil	Right Of Use Asset And Liability RightOfUseAssetAndLiability	0	usd
	fil	Warrants Issued With Promissory Notes WarrantsIssuedWithPromissoryNotes	185788	usd
	fil	Warrants Issued With Promissory Notes WarrantsIssuedWithPromissoryNotes	302537	usd
	fil	Accrual Of Preferred Stock Interest AccrualOfPreferredStockInterest	120000	usd
	fil	Accrual Of Preferred Stock Interest AccrualOfPreferredStockInterest	120000	usd
	fil	Conversion Of Notes Into Common Stock ConversionOfNotesIntoCommonStock	0	usd
	fil	Conversion Of Notes Into Common Stock ConversionOfNotesIntoCommonStock	415875	usd
	fil	Purchase Of Property And Equipment With Common Stock PurchaseOfPropertyAndEquipmentWithCommonStock	0	usd
	fil	Purchase Of Property And Equipment With Common Stock PurchaseOfPropertyAndEquipmentWithCommonStock	700000	usd
	fil	Purchase Of Property And Equipment With Accounts And Notes Payable PurchaseOfPropertyAndEquipmentWithAccountsAndNotesPayable	0	usd
	fil	Purchase Of Property And Equipment With Accounts And Notes Payable PurchaseOfPropertyAndEquipmentWithAccountsAndNotesPayable	55016	usd
	fil	Settlement Of Accounts Payable With Sale Of Equipment SettlementOfAccountsPayableWithSaleOfEquipment	0	usd
	fil	Settlement Of Accounts Payable With Sale Of Equipment SettlementOfAccountsPayableWithSaleOfEquipment	212067	usd
CY2019Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	3000000	usd
CY2023Q2	fil	Working Capital Deficit WorkingCapitalDeficit	8354673	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61123034	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2006934	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font:10pt Times New Roman;margin:0;text-align:justify">Use of Estimates</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The preparation of consolidated financial statements in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions about collection of accounts receivable, useful life of fixed assets and intangible assets, borrowing rate considered for operating lease right-of-use asset and related operating lease liability, and assumptions used in Black-Scholes valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.</p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font:10pt Times New Roman;margin:0;text-align:justify">Financial Statement Reclassification</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.</p>
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	454012	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	470532	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font:10pt Times New Roman;margin:0;text-align:justify">Concentration of Credit Risks</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The Company is subject to concentrations of credit risk primarily from cash and cash equivalents and accounts receivable.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The Company’s cash and restricted cash accounts are held at a financial institution and are insured by the Federal Deposit Insurance Corporation, or the FDIC, up to $250,000. From time-to-time, the Company’s bank balances exceed the FDIC insurance limit. To reduce its risk associated with the failure of such financial institutions, the Company periodically evaluates the credit quality of the financial institution in which it holds deposits. As of June 30, 2023, the Company had $798,166 in excess of federally insured limits.</p>
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
	us-gaap	Advertising Expense AdvertisingExpense	27969	usd
	us-gaap	Advertising Expense AdvertisingExpense	18411	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11202	usd
CY2022	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	339768	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	64773	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	64772	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16866	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47907	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	53570	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	3276193	usd
CY2023Q2	us-gaap	Depreciation Depreciation	2831	usd
CY2022Q2	us-gaap	Depreciation Depreciation	407252	usd
	us-gaap	Depreciation Depreciation	5664	usd
	us-gaap	Depreciation Depreciation	788452	usd
CY2021Q2	us-gaap	Notes Payable NotesPayable	2957000	usd
CY2021Q2	fil	Outstanding Amount OutstandingAmount	158625	usd
CY2021Q2	fil	Balance Paid Per Month BalancePaidPerMonth	20000	usd
CY2021Q2	fil	Total Paid Per Month TotalPaidPerMonth	138625	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	250000	usd
CY2021Q4	fil	Accrued Interest Rate AccruedInterestRate	0.12	pure
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3794914	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	565814	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	50882	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	23702	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	105783	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	4541094	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	3794914	usd
CY2021Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	the Company effected a reverse split of its outstanding common stock in the ratio of 1-for-15
CY2023Q2	fil	Shares Issued As Payment For Accrued Interest Value SharesIssuedAsPaymentForAccruedInterestValue	405000	usd
CY2023Q2	fil	Payments In Advance Of Securities Date PaymentsInAdvanceOfSecuritiesDate	0	usd
CY2022Q4	fil	Payments In Advance Of Securities Date PaymentsInAdvanceOfSecuritiesDate	217500	usd
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
	us-gaap	Dividends Paidinkind DividendsPaidinkind	120000	usd
	us-gaap	Dividends Paidinkind DividendsPaidinkind	120000	usd
CY2022	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	339768	usd
	fil	Right Of Use Asset And Liability RightOfUseAssetAndLiability	187863	usd
CY2023Q1	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	599047	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Real Estate ProceedsFromSaleOfRealEstate	699000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	9253	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	13219	usd
CY2023Q2	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	0	usd
CY2022Q4	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	599047	usd
CY2023Q2	fil	Due To Related Party DueToRelatedParty	501140	usd
CY2022Q4	fil	Due To Related Party DueToRelatedParty	503259	usd
CY2021Q4	us-gaap	Proceeds From Legal Settlements ProceedsFromLegalSettlements	100000	usd
CY2021Q4	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	40000	usd
CY2021Q4	fil	Monthly Installment MonthlyInstallment	1250	usd
CY2023Q2	fil	Balance Legal Amount Paid During The Period BalanceLegalAmountPaidDuringThePeriod	32500	usd
CY2022Q4	fil	Balance Legal Amount Paid During The Period BalanceLegalAmountPaidDuringThePeriod	41250	usd

Files In Submission

Name	View Source	Status
cnfn-20230630_lab.xml	Edgar Link	unprocessable
cnfn-20230630_def.xml	Edgar Link	unprocessable
cnfn-20230630_cal.xml	Edgar Link	unprocessable
0001096906-23-001595-index-headers.html	Edgar Link	pending
0001096906-23-001595-index.html	Edgar Link	pending
0001096906-23-001595.txt	Edgar Link	pending
0001096906-23-001595-xbrl.zip	Edgar Link	pending
cfn_ex31z1.htm	Edgar Link	pending
cfn_ex32z1.htm	Edgar Link	pending
cnfn-20230630.htm	Edgar Link	pending
cnfn-20230630.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
cnfn-20230630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cnfn-20230630_htm.xml	Edgar Link	completed
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CNFN
CFN Enterprises Inc. Stock $cnfn

2023 Q3 Form 10-Q Financial Statement

#000109690623001595 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNFN CFN Enterprises Inc. Stock $cnfn

2023 Q3 Form 10-Q Financial Statement

#000109690623001595 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNFN
CFN Enterprises Inc. Stock $cnfn